Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignances worldwide, with an urgent need for novel therapies (11). Patients with PDAC often present with de novo metastatic disease, typically in the liver or lung; brain metastases are rare (22). 68GaGa-DOTA-5G, a
Foster et al. (Wed,) studied this question.